Advertisement Curexo Technology names new president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Curexo Technology names new president and CEO

Curexo Technology, a developer of image-directed surgical robotic products for orthopedic applications, has appointed Brent Mittelstadt as its new president and CEO.

Mr Mittelstadt began research in surgical robotics in 1986 as a visiting research scientist at the IBM TJ Watson Research Center and is responsible for much of the early development of computed tomography guided robotic systems for joint replacement surgery.

In 1990, with initial investment from IBM, Mr Mittelstadt co-founded Integrated Surgical Systems (ISS) to develop a surgical robot system to assist with hip and knee replacement surgery. After leaving ISS in June 2002, Mr Mittelstadt took a position at Consensus Orthopedics, where he was director of marketing.

Taehoon Kim, chairman of Curexo, said: “We are very excited to have Mr Mittelstadt as a member of our senior management team. The unique combination of his Robodoc knowledge and our recent FDA clearance provides Mr Mittelstadt an immense opportunity to lead the company into the next phase of commercializing our products into the US market.”